Algeria
Egypt
Israel
Jordan
Lebanon
Libya
Morocco
Palestine *
Syria *
TunisiaEU4Monitoring Drugs trendspotter briefing – Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in south European Neighbourhood Policy area
December 25, 2020
Share on 
The emergence of new drug trafficking routes, the reduced availability of drug-related health services and the adaptation of drug treatment protocols during the COVID-19 pandemic are among the findings highlighted in a new report of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
The report presents the key results of an EMCDDA trendspotter study, prepared in consultation with some 20 experts from seven southern ENP countries, providing a snapshot of the state of play with respect to the impact of COVID-19 on drug markets and people who use drugs in south ENP countries between March and June 2020.
The publication is released in the framework of the EU4Monitoring Drugs project, funded by the EU and launched in 2019.
EU4Monitoring Drugs trendspotter briefing - Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in so
Related Publications
